| Turchia | Austria | Spagna | |
| Terapia con protoni | da $70,000 | da $80,000 | da $25,550 |
| Sistema robotico Da Vinci | da $9,500 | da $22,000 | da $17,000 |
| Resezione gastrica | da $16,470 | da $22,000 | da $9,000 |
| Radioterapia per il cancro allo stomaco | da $3,250 | da $6,973 | da $4,065 |
| Immunoterapia con Keytruda (Pembrolizumab) | da $3,300 | da $15,000 | da $15,000 |
Dr. David Kuczer is a specialist in radio-oncology with many years of experience in cancer diagnosis and treatment. He offers fast access to precise radiotherapy based on current scientific standards.
He is a member of the Cancer Center at the Vienna Private Clinic. He presents each patient to the in-house tumor board. This allows an interdisciplinary discussion by an internationally renowned team and helps select the best treatment.
All radiation treatments are provided in close cooperation with Amethyst Radiotherapy at the Vienna Private Clinic.
Univ. Prof. Dott. Christoph Zielinski è una figura internazionale di spicco in oncologia medica e immunoterapia con oltre 40 anni di lavoro pionieristico. Attualmente dirige l'International Oncology Center presso la Wiener Privatklinik.
Il Dott. Harald Rosen è specializzato in procedure endoscopiche avanzate per il cancro gastrico presso il Wiener Privatklinik, combinando la precisione chirurgica con l'esperienza in gastroenterologia.
Il medico è un distinto oncologo medico e internista austriaco con oltre due decenni di esperienza, specializzato in cancro al seno, neoplasie ginecologiche e terapie mirate contro il cancro. Laureato all'Università di Vienna, il medico ha completato la residenza in medicina interna e oncologia medica presso l'Università Medica di Vienna. Il medico ha contribuito ai primi studi clinici sulle terapie mirate ed è un'autorità leader nel trattamento personalizzato del cancro.<\/p>
Attualmente serve come consulente senior presso il Wiener Privatklinik e continua il lavoro accademico presso l'Università Medica di Vienna, il medico si concentra sulla terapia sistemica individualizzata del cancro, l'immunoterapia e la ricerca oncologica traslazionale. La ricerca del medico include lo sviluppo di biomarcatori e meccanismi di resistenza ai farmaci mirati, con pubblicazioni su riviste internazionali di spicco.<\/p>
Austria offers high-standard stomach cancer care at centers like Wiener Privatklinik and Vienna General Hospital. These facilities provide advanced treatments including robotic gastrectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Specialized teams utilize multidisciplinary tumor boards to ensure precise, individualized oncology protocols for international patients.
Bookimed Expert Insight: While public facilities like Vienna General Hospital handle massive patient volumes of 595,000 annually, private centers offer specific access to university professors. For example, prominent experts like Prof. Dr. Wolfgang Köstler or Univ. Prof. Dr. Christoph Zielinski consult at Wiener Privatklinik. This allows patients to receive university-level expertise with the speed and personalized care of a private boutique environment.
Patient Consensus: Patients note that being in good hands with specialists like Prof. Dr. Zielinski provides significant peace of mind. Many emphasize that doctors are professional and kind, making the treatment process feel supportive and reliable.
Austria offers advanced stomach cancer treatments including precision surgery, immunotherapy, and targeted molecular therapies. Patients access multidisciplinary care at university-affiliated centers and private clinics. Key modalities include D2 lymphadenectomy, the FLOT chemotherapy regimen, and robotic-assisted gastrectomy. Leading specialists often hold professorships at the Medical University of Vienna.
Bookimed Expert Insight: Data shows that choosing a private facility like Wiener Privatklinik provides direct access to the same department heads who run the public Vienna General Hospital (AKH). This allows patients to bypass public waitlists while receiving care from world-recognized experts like Prof. Dr. Christoph Zielinski. These specialists often present complex cases to interdisciplinary tumor boards for optimized treatment planning.
Patient Consensus: Patients note it's important to have a dedicated coordinator to navigate the local bureaucracy. Reviews frequently highlight that surgeons like Prof. Dr. Harald Rosen provide professional and supportive care that makes families feel their loved ones are in good hands.
Stomach cancer treatment in Austria is highly successful with a 5-year survival rate of 33.6%. This significantly exceeds the European average of 25.1%. Austrian oncology centers achieve 85% to 90% efficacy rates for early-stage cases. Advanced surgical techniques have also reduced postoperative mortality to 0.4%.
Bookimed Expert Insight: Success in Austria is driven by extreme surgical specialization and volume. Prof. Dr. Harald Rosen at Wiener Privatklinik has performed over 5,000 procedures. This level of experience correlates with the low complication rates reported at clinics like Döbling Private Hospital. High-volume centers in Vienna often serve over 16,000 patients annually. This concentration of expertise ensures surgeons maintain precision in complex gastrectomies and robotic-assisted procedures.
Patient Consensus: Patients emphasize the kindness and professionalism of top oncologists like Univ. Prof. Dr. Christoph Zielinski. Many note that being in `good hands` at these specialized Viennese clinics provides significant emotional relief during recovery.
During your first consultation for stomach cancer in Austria, prioritize questions about staging precision and interdisciplinary treatment plans. Ask about the specific TNM stage and if advanced diagnostics like PET-CT or diagnostic laparoscopy are necessary to confirm your surgical eligibility.
Bookimed Expert Insight: Patients at top Viennese centers often benefit from a double-layered expertise model. For instance, at Wiener Privatklinik, Dr. David Kuczer presents every case to an in-house tumor board. This ensures that even in private settings, you receive a university-level consensus. This collaborative approach between international oncology leaders and specialized surgeons reduces the risk of missed therapeutic opportunities.
Patient Consensus: Patients emphasize pushing for staging confidence before starting treatment. Many note that self-paying can significantly shorten the wait time for chemotherapy from weeks to just days.